Neutra prepares to roll out new game-changing technology in indoor horticulture industry

As Neutra Corp. (OTCBB: NTRR) and its joint venture partner prepare to roll out a new, game-changing technology in the indoor horticulture industry, the company announced today that work has already begun on new, customizable solutions for growing operations with uncommon requirements.

NTRR is working to assist partner Vertigo Technologies in delivering a turn-key solution for indoor horticulturalists that could be especially useful for growers in Colorado and other booming horticultural markets for whom high yields and speedy production are especially crucial to business. Additionally, the partners are developing anti-microbial solutions that could one day eliminate the need for pesticides in the herb's cultivation.

Now, the joint venture is exploring breaking down its all-in-one grow system into high-quality parts and modules that can be purchased separately and configured to create highly customized lighting, irrigation and anti-pest systems for indoor farms of all shapes and sizes.

"We plan to make it easier and more affordable than ever before to quickly create top-notch, money-saving horticulture systems anywhere," said NTRR CEO Sydney Jim. "This new initiative was sparked by consumer feedback we've received on our prototype systems: Growers want more and more options for customization."

As the cannabis industry in the U.S. rapidly approaches a regulatory tipping point, Neutra Corp. is hard at work marketing and developing top technological innovations designed to dramatically improve efficiency across the fast-growing market. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis and other nutraceuticals in approved markets, Neutra Corp. plans to enjoy unprecedented growth in 2014 alongside Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Vape Holdings Inc. (OTCBB: VAPE), delivering technological advancements in the cultivation and processing of cannabis in approved markets.

Source:

Neutra Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aptamer extends agreement with genetic medicines customer